• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Genetically proxied IL-6 receptor inhibition and risk of polymyalgia rheumatica.

作者信息

Zhao Sizheng Steven, Gill Dipender

机构信息

Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Science, School of Biological Sciences, Faculty of Biological Medicine and Health, The University of Manchester, Manchester, UK

Centre of Excellence in Genetics, Novo Nordisk Research Centre Oxford, Oxford, UK.

出版信息

Ann Rheum Dis. 2022 Sep 12;81(10):1480-1482. doi: 10.1136/annrheumdis-2022-222578.

DOI:10.1136/annrheumdis-2022-222578
PMID:35701152
Abstract
摘要

相似文献

1
Genetically proxied IL-6 receptor inhibition and risk of polymyalgia rheumatica.基因代理的白细胞介素-6受体抑制与风湿性多肌痛风险
Ann Rheum Dis. 2022 Sep 12;81(10):1480-1482. doi: 10.1136/annrheumdis-2022-222578.
2
Genetically proxied IL-1 receptor antagonism and risk of polymyalgia rheumatica.基因代理的白细胞介素-1受体拮抗作用与风湿性多肌痛风险
Rheumatology (Oxford). 2024 Feb 1;63(2):e43-e44. doi: 10.1093/rheumatology/kead423.
3
Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.基于遗传邻近性的 PCSK9 抑制与前列腺癌风险的关联：一项孟德尔随机化研究。
PLoS Med. 2023 Jan 3;20(1):e1003988. doi: 10.1371/journal.pmed.1003988. eCollection 2023 Jan.
4
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.托珠单抗治疗糖皮质激素治疗的活动性多发性肌痛患者的疾病活动度：一项随机临床试验。
JAMA. 2022 Sep 20;328(11):1053-1062. doi: 10.1001/jama.2022.15459.
5
Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis.风湿性多肌痛和巨细胞动脉炎患者的组织细胞因子模式。
Ann Intern Med. 1994 Oct 1;121(7):484-91. doi: 10.7326/0003-4819-121-7-199410010-00003.
6
Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?托珠单抗在风湿性多肌痛和合并风湿性多肌痛的巨细胞动脉炎中是否有效且安全？
Cureus. 2022 Aug 2;14(8):e27606. doi: 10.7759/cureus.27606. eCollection 2022 Aug.
7
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.基于遗传关联的降糖药物靶点干预与癌症风险：一项孟德尔随机化分析。
Diabetologia. 2023 Aug;66(8):1481-1500. doi: 10.1007/s00125-023-05925-4. Epub 2023 May 12.
8
Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.巨细胞动脉炎和风湿性多肌痛中的血清免疫球蛋白G4
Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):94-97. Epub 2016 Dec 2.
9
[Polymyalgia rheumatica].[风湿性多肌痛]
Orv Hetil. 2006 Sep 17;147(37):1791-802.
10
[Carpal tunnel syndrome as initial manifestation of polymyalgia rheumatica].[腕管综合征作为风湿性多肌痛的首发表现]
Medicina (B Aires). 1996;56(1):55-6.

引用本文的文献

1
IL6 genetic perturbation mimicking IL-6 inhibition is associated with lower cardiometabolic risk.模仿白细胞介素-6抑制的白细胞介素-6基因干扰与较低的心脏代谢风险相关。
Nat Cardiovasc Res. 2025 Aug 26. doi: 10.1038/s44161-025-00700-7.
2
Human Genetics Informing Drug Development in Cardiovascular Disease: Interleukin-6 Signaling as a Case Study.人类遗传学为心血管疾病药物研发提供信息：以白细胞介素-6信号传导为例的研究
Circ Genom Precis Med. 2025 Aug;18(4):e005103. doi: 10.1161/CIRCGEN.125.005103. Epub 2025 Jul 28.
3
Leveraging large-scale multi-omics evidences to identify therapeutic targets from genome-wide association studies.
利用大规模多组学证据从全基因组关联研究中鉴定治疗靶点。
BMC Genomics. 2024 Nov 19;25(1):1111. doi: 10.1186/s12864-024-10971-2.
4
Use of Mendelian randomization to assess the causal status of modifiable exposures for rheumatic diseases.利用孟德尔随机化评估风湿性疾病可改变暴露因素的因果关系。
Best Pract Res Clin Rheumatol. 2024 Dec;38(4):101967. doi: 10.1016/j.berh.2024.101967. Epub 2024 Jun 30.
5
Modifiable risk factors and inflammation-related proteins in polymyalgia rheumatica: genome-wide meta-analysis and Mendelian randomization.风湿性多肌痛中可改变的风险因素及炎症相关蛋白：全基因组荟萃分析和孟德尔随机化研究
Rheumatology (Oxford). 2025 May 1;64(5):3012-3018. doi: 10.1093/rheumatology/keae308.
6
Mendelian randomization as a tool to inform drug development using human genetics.孟德尔随机化作为一种利用人类遗传学为药物研发提供信息的工具。
Camb Prism Precis Med. 2023 Feb 8;1:e16. doi: 10.1017/pcm.2023.5. eCollection 2023.
7
IL-6 receptor inhibition and risk of sarcoidosis: a Mendelian randomization study.白细胞介素-6受体抑制与结节病风险：一项孟德尔随机化研究
Rheumatology (Oxford). 2024 Apr 2;63(4):e118-e119. doi: 10.1093/rheumatology/kead613.
8
Genetically proxied IL-1 receptor antagonism and risk of polymyalgia rheumatica.基因代理的白细胞介素-1受体拮抗作用与风湿性多肌痛风险
Rheumatology (Oxford). 2024 Feb 1;63(2):e43-e44. doi: 10.1093/rheumatology/kead423.
9
Efficacy and Safety of Tofacitinib in Patients with Polymyalgia Rheumatica (EAST PMR): An open-label randomized controlled trial.托法替布治疗巨细胞动脉炎（EAST PMR）：一项开放性随机对照试验的疗效和安全性。
PLoS Med. 2023 Jun 29;20(6):e1004249. doi: 10.1371/journal.pmed.1004249. eCollection 2023 Jun.
10
Elderly-onset rheumatoid arthritis vs. polymyalgia rheumatica: Differences in pathogenesis.老年发病的类风湿关节炎与风湿性多肌痛：发病机制的差异
Front Med (Lausanne). 2023 Jan 12;9:1083879. doi: 10.3389/fmed.2022.1083879. eCollection 2022.